prostate cancer
Conditions
Interventions
Prostate biopsy using biojet system
Sponsors
Okayama University Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Target patients who meet all the following criteria 1) Patients with serum PSA level between 2.5 ng / ml and 50 ng / ml 2) PIRADS score 3 or more on MRI before biopsy 3) Patients 20 years of age or older at the time of consent acquisition 4) Patients who obtained written consent by the patient's own free will after sufficient understanding after participating in this study
Exclusion criteria
Exclusion criteria: I. A patient who is judged not to contribute to a patient's life prognosis by a definite diagnosis of prostate cancer II. Patients suspected of developing prostate cancer with serum PSA> 50 ng / ml III. Patients suspected of having advanced prostate cancer by rectal examination IV. Patients suspected of having advanced prostate cancer by MRI V. Patients who can not have prostate biopsy due to blood coagulation abnormality VI. Patients who can not be under spinal anesthesia, sacral anesthesia or general anesthesia because they have allergies to anesthetic agents VII. Other patients who were judged inappropriate by the doctor in charge of this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biopsy positive rate | — |
Secondary
| Measure | Time frame |
|---|---|
| safety such as bleeding, infection after biopsy | — |
Countries
Japan
Contacts
Public Contacttakamoto atsushi
Okayama University Hospital Department of urology
Outcome results
None listed